Eli Lilly and Company's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Other-Long-Term-Assets" stands at 6.43 Billion United States Dollars as of 09/30/2025, the highest value since 03/31/2019.
As of the end of Eli Lilly and Company's third quarter, the item "Other Long Term Assets" stands at 6.43 Billion USD. This represents an increase of 3.33 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 25.59 percent compared to the value the year prior.
The 1 year change in percent is 25.59.
The 3 year change in percent is 41.82.
The 5 year change in percent is 108.95.
The 10 year change in percent is 230.54.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Johnson & Johnson - Other Long Term Assets | 486,508,953,600.00 |
![]() | AbbVie Inc - Other Long Term Assets | 399,570,305,024.00 |
![]() | Roche Holding AG - Other Long Term Assets | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Other Long Term Assets | 280,205,508,085.11 |
![]() | Novartis AG - Other Long Term Assets | 255,096,620,580.91 |